Trading Signals: BAX Stock Price Prediction and Forecast (Mon. Dec. 1, 2014 - Wed. Sep. 27, 2023)(Baxter International Inc.)
| BAX latest price $65.4800 (0.71%) ($63.9700 - $65.7000) on Mon. Dec. 10, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.8% (three month average) | RSI | 47 | Latest Price | $65.4800(0.71%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BAX declines -0.9% a day on average for past five trading days. | Weekly Trend | BAX advances 0.9% a week on average for past two weeks. | Market Behavior | Rotation from value to growth for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support BAX advance at 0% a week (0% probability) XLV(57%) SPLV(53%) VYM(52%) XLP(52%) IVE(49%) | Factors Impacting BAX price | BAX will decline at least -0.9% in a week (0% probabilities). TLT(-20%) DIA(-13%) GDXJ(-11%) VIXM(-10%) VXX(-9%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.9% (StdDev 1.8%) | Hourly BBV | 0 () | Intraday Trend | 0.8% | | | |
|
Resistance Level | $65.83 | 5 Day Moving Average | $66.75(-1.9%) | 10 Day Moving Average | $67.04(-2.33%) | 20 Day Moving Average | $65.83(-0.53%) | To recent high | -15.8% | To recent low | 6.4% | Market Cap | $33.407b | | | | Baxter International, Inc. provides portfolio of essential renal and hospital products, including acute and chronic dialysis, sterile IV solutions, infusion systems and devices, parenteral nutrition therapies; premixed and oncolytic injectable, bio surgery products and anesthetics, drug reconstitution systems; and pharmacy automation, software and services. It operates through the following segment: Americas, Europe, Middle East & Africa and Asia-Pacific. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL. |